ISD Immunotech
ISD Immunotech is developing a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE) patients.
ISD Immunotech has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Aarhus, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Aarhus, Denmarkwww.isd-immunotech.com ↗
Total raised
€0
€0
Funding rounds
1
Investors
2
distinct backers
Active since
2021-10
latest 2021-10
Funding by year
EUR raised per yearISD Immunotech — funding by year — interactive chart.
Data table
| ISD Immunotech — funding by year | |
|---|---|
| 2021 | €0 |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-04 | Other | — | EIR Ventures,Novo Seeds | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData